Brewer Science Acquires Heraeus Epurio Semiconductor Chemicals Business to Expand US Manufacturing

Brewer Science has finalized the acquisition of Heraeus Epurio's semiconductor chemicals business, strengthening its position in the advanced semiconductor materials market. The transaction includes the production facility located in Dayton, United States, along with the associated sales and technical support teams operating across Asia. By integrating these assets into its operations, Brewer Science is expanding its manufacturing capabilities while enhancing support for customers involved in advanced semiconductor production.

Acquisition Expands In-House Semiconductor Chemical Production

The acquisition enables Brewer Science to manufacture ultrapure semiconductor chemicals internally, further strengthening its production capabilities. The expanded portfolio includes photoacid generators, photoinitiators, monomers, and crosslinkers that play a critical role in advanced chip manufacturing processes. Bringing these specialized chemical technologies under one organization is expected to improve operational efficiency while supporting the increasing demand for high-performance semiconductor materials across global markets.

Strengthening Quality Standards Across the Supply Chain

With the newly acquired manufacturing assets and technical expertise, Brewer Science is reinforcing its Zero Defects quality standards throughout its supply chain. Internal production of critical semiconductor chemicals is expected to provide greater process control, helping improve manufacturing consistency, product reliability, and supply assurance for customers. The move aligns with the company's long-term strategy of delivering dependable materials that meet the stringent quality requirements of advanced semiconductor fabrication.

Expanded U.S. Manufacturing Footprint

The acquisition also increases Brewer Science's manufacturing presence in the United States. The addition of the Dayton production facility complements the company's Arizona Innovation Center, which opened in 2025, as well as its existing operations in Missouri. Together, these facilities strengthen Brewer Science's domestic manufacturing network and support its ongoing investments in semiconductor innovation and production capacity.

Key Highlights of the Acquisition

• Brewer Science completed the acquisition of Heraeus Epurio's semiconductor chemicals business.
• The transaction includes the Dayton, Ohio production facility.
• Sales and technical support teams in Asia are part of the acquisition.
• Ultrapure semiconductor chemical manufacturing will now be conducted in-house.
• The portfolio includes photoacid generators, photoinitiators, monomers, and crosslinkers.
• The acquisition strengthens Zero Defects quality standards and expands U.S. manufacturing operations.

Brewer Science Acquisition Overview

Frequently Asked Questions

What does Brewer Science's acquisition of Heraeus Epurio's semiconductor chemicals business include?
The acquisition covers Heraeus Epurio's semiconductor chemicals business, including its production facility in Dayton, Ohio, along with related sales and technical support teams in Asia. It also adds a portfolio of ultrapure semiconductor chemicals such as photoacid generators, photoinitiators, monomers, and crosslinkers. The transaction enables Brewer Science to manufacture these critical materials internally, strengthening product quality, improving supply chain reliability, and expanding its U.S. manufacturing capabilities for advanced semiconductor production.